Concepedia
Publication | Open Access
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
58
Citations
17
References
2020
Year
Page 1